Beverly Huss is a medical device entrepreneur, board director and mentor with more than two decades of general management and board director experience in both public and venture backed companies. She was formerly Executive Chair of Madorra, Inc. a women’s health company focused on improving the quality of life after menopause. She was co-founder and CEO of Pagonia Medical. Previously, Beverly was President and CEO of Qool Therapeutics, Inc. a tissue preservation company. Beverly was co-founder and CEO of Vibrynt, Inc. a company that developed a novel minimally invasive therapeutic device for the treatment of morbid obesity. Prior to this, Beverly was with Santa Clara, California-based Guidant since 1986, fulfilling a variety of executive roles within the company’s various medical device divisions. She managed the worldwide Endovascular Solutions business as President and quadrupled worldwide revenues to $150 million for the carotid and peripheral vascular business in four years.

Prior to this Beverly held several executive level positions as Vice President of Guidant’s Canada and Latin America operations, Vice President of Vascular Intervention Global Marketing and Vice President of the Stent Business Unit where she built the company’s coronary stent business, a market leader for 27 of 28 quarters with revenue growth of zero to $1 billion and 90% gross margins in three years. Earlier in her career, Beverly held engineering positions at both Honeywell Defense Systems Division and Jones and Laughlin Steel. Additionally, she served as chairperson of the Silicon Valley American Heart Association and as a senior advisor to Pervasis Therapeutics, a Cambridge, MA based cell therapy company.

Beverly holds a M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois. Beverly has several patents to her credit in the cardiovascular, obesity and temperature management medical device areas. Beverly serves on the boards of Accuray (chair of the Accuray compensation committee), Iridex (chair of the Iridex compensation committee), InfuSystems Holdings (co-chair of compensation committee) Ancora Heart, and Vicarious Surgical. She serves on the University of Illinois Material Science and Engineering steering Committee and Biomedical Engineering Steering Committee. She previously served on the boards of Madorra, Kalera Medical, Surefire Medical, Ulthera, Dade Behring, Inc., Wright Medical Inc., and Artes Medical. She is a business coach and mentor in the Stanford University Biodesign Fellowship Program.

Beverly was the recipient of the 2013 University of Illinois College of Engineering Alumni Award for distinguished leadership in the medical device industry. Beverly was named a 2024 Director to Watch by Directors and Boards and holds a National Association of Corporate Directors Certification.